News Release
Study Finds Relationship Between Discrimination and Frailty in Black Cancer Survivors
March 20th, 2023
Cancer-focused work takes place at Georgetown University’s Lombardi Comprehensive Cancer Center, the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the Washington area.
Georgetown Lombardi serves as the research engine for MedStar Health, its clinical partner.
Georgetown Lombardi is also an NCI recognized consortium with John Theurer Cancer Center/Hackensack Meridian Health in Bergen County, New Jersey. The consortium reflects an integrated cancer research enterprise with scientists and physician-researchers from both locations.
Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational and clinical research, patient care, community education and outreach to service communities throughout the Washington region, while its consortium member John Theurer Cancer Center/Hackensack Meridian Health serves communities in northern New Jersey.
News Release
Study Finds Relationship Between Discrimination and Frailty in Black Cancer Survivors
March 20th, 2023
GUMC Stories
Key Studies Conducted at Georgetown Lombardi Lead to Better Treatment for People With Melanoma
March 1st, 2023
GUMC Stories
Ruesch Symposium Participants Encourage Patients to Consider Clinical Trials
December 4th, 2022
News Release
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
December 1st, 2022